» Articles » PMID: 10720831

Mitotic Index is the Best Predictive Factor for Survival of Patients with Resected Hepatocellular Carcinoma

Overview
Journal Dig Surg
Date 2000 Mar 18
PMID 10720831
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In patients with hepatocellular carcinoma (HCC), tumor recurrence is not infrequent after resection. It is presumed that characteristics of the tumor such as cellular malignancy might influence the prognosis of the patients in association with tumor stage and radicality of the procedure.

Methods: Univariate and multivariate analyses were used to retrospectively determine the clinicopathologic factors potentially related to survival in 40 patients who underwent hepatectomy for HCC.

Results: In univariate analysis, tumor stage I or II, mitotic index of 4 or less/10 random high-power fields, solitary tumor, and curative resection were significantly correlated with better survival. In multivariate analysis, the mitotic index and surgical curability were independently significant variables influencing survival of patients, and the mitotic index was the best predictive factor. A highly significant correlation was found between the mitotic index and Ki-67 labeling index. Compared to tumors with a mitotic index of 4 or less, those with a mitotic index of 5 or more had a higher association with multiple tumors and advanced tumor stage, which preclude curative resection.

Conclusion: Analysis of the mitotic index is quite simple, and the mitotic index could be a useful factor for predicting the long-term survival of patients with HCC following hepatic resection.

Citing Articles

Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma.

Dos Santos M, Franca A, Lima Filho A, Florentino R, Diniz P, Oliveira Lemos F Oncol Lett. 2021; 23(1):32.

PMID: 34966448 PMC: 8669656. DOI: 10.3892/ol.2021.13150.


Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant or Wild-Type Gene.

Lin J, Liu T, Andriani V, Athoillah M, Wang C, Yang P J Pers Med. 2021; 11(11).

PMID: 34834551 PMC: 8623741. DOI: 10.3390/jpm11111199.


The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.

Ha S, Choi M, Lee T, Park C Cancer Res Treat. 2015; 48(1):180-9.

PMID: 25797572 PMC: 4720078. DOI: 10.4143/crt.2014.321.


Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.

Nanashima A, Tanaka K, Yamaguchi H, Shibasaki S, Morino S, Yoshinaga M Dig Dis Sci. 2003; 48(8):1517-22.

PMID: 12924646 DOI: 10.1023/a:1024759606402.


The prognostic molecular markers in hepatocellular carcinoma.

Qin L, Tang Z World J Gastroenterol. 2002; 8(3):385-92.

PMID: 12046056 PMC: 4656407. DOI: 10.3748/wjg.v8.i3.385.